Oxidized low density lipoprotein (Ox-LDL) has a plethora of components that
are not present in native LDL, Their presence and quantity depends on the
nature, type, and extent of oxidation, Lipids esterified to oxidized fatty
acids are the major components formed during the early phase of oxidation a
nd these show a number of proatherogenic properties in in vitro cell cultur
e systems. Recently, evidence has been forthcoming to suggest that some of
these oxidized lipids also could elicit "antioxidant-antiatherogenic" respo
nses from cells. Moreover, some of the cellular effects of Ox-LDL that were
previously interpreted as atherogenic could also be reinterpreted to sugge
st an antiatherogenic cellular response. In addition to the above, the anti
oxidants that are carried in lipoproteins could have anomalous behavior att
ributable to their metabolism, ability to be internalized by arterial cells
, and the presence of oxidative systems that could render them prooxidants.
In conclusion, there are numerous contributing factors that need to be stu
died and understood before antioxidant therapy becomes an option for the tr
eatment for cardiovascular diseases.